Form 4 for RMD ResMed|
Accepted 2026-08-06 14:29:31 ET · period of report 2026-08-05 · accession 0000943819-26-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-06 14:29 | 2026-08-05 | RMD | FARRELL PETER C | Dir | S - Sale | $225.00 | -8,000 | 52.8K | -13% | -$1.80M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2026-08-05 | S | D | 8,000 | $225.00 | 52,773 | D | — | — | (F1) The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025. |